A rapid method for the preparation of ultrapure, functional lysosomes using functionalized superparamagnetic iron oxide nanoparticles

Methods in Cell Biology

Volumn 126, Issue , 2015, Pages 21-43

  Walker, Mathew W ^a   Lloyd Evans, Emyr ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Lysosomal purification; Lysosome; Subcellular fractionation; Superparamagnetic nanoparticle

Indexed keywords

MAGNETITE NANOPARTICLE;

ANIMAL; CELL FRACTIONATION; CHEMISTRY; CHO CELL LINE; CRICETULUS; DENSITY GRADIENT CENTRIFUGATION; ELECTROPHORESIS; HAMSTER; HUMAN; LYSOSOME; PHYSIOLOGY; PROCEDURES; STAINING;

ANIMALS; CELL FRACTIONATION; CENTRIFUGATION, DENSITY GRADIENT; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHORESIS; HUMANS; LYSOSOMES; MAGNETITE NANOPARTICLES; STAINING AND LABELING;

EID: 84922953294     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.mcb.2014.10.019     Document Type: Article

References (38)

1. Arborgh B., Ericsson J.L., Glaumann H. Method for the isolation of iron-loaded lysosomes from rat liver. FEBS Letters 1973, 32(1):190-194.
2. Beaumelle B.D., Gibson A., Hopkins C.R. Isolation and preliminary characterization of the major membrane boundaries of the endocytic pathway in lymphocytes. The Journal Cell Biology 1990, 111(5 Pt 1):1811-1823.
3. Berry C.C., Wells S., Charles S., Curtis A.S. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24(25):4551-4557.
4. Bonten E.J., Arts W.F., Beck M., Covanis A., Donati M.A., Parini R., et al. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Human Molecular Genetics 2000, 9(18):2715-2725.
5. Brooks D.A. The endosomal network. International Journal of Clinical Pharmacology and Therapeutics 2009, 47(Suppl. 1):S9-S17.
6. Chen F.W., Gordon R.E., Ioannou Y.A. NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein. Biochemical Journal 2005, 390(Pt 2):549-561. 10.1042/BJ20050236.
7. Choudhury A., Marks D.L., Pagano R.E. Use of Rab GTPases to study lipid trafficking in normal and sphingolipid storage disease fibroblasts. Methods in Enzymology 2005, 403:166-182. 10.1016/S0076-6879(05)03014-4.
8. Churchill G.C., Okada Y., Thomas J.M., Genazzani A.A., Patel S., Galione A. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 2002, 111(5):703-708.
9. Cox T.M., Cachon-Gonzalez M.B. The cellular pathology of lysosomal diseases. The Journal of Pathology 2012, 226(2):241-254. 10.1002/path.3021.
10. Diettrich O., Mills K., Johnson A.W., Hasilik A., Winchester B.G. Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders. FEBS Letters 1998, 441(3):369-372.
11. Doray B., Ghosh P., Griffith J., Geuze H.J., Kornfeld S. Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science 2002, 297(5587):1700-1703. 10.1126/science.1075327.
12. de Duve D. The peroxisome: a new cytoplasmic organelle. Proceedings of the Royal Society of London Series B: Biological Sciences 1969, 173(1030):71-83.
13. Duvvuri M., Krise J.P. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. Molecular Pharmaceutics 2005, 2(6):440-448. 10.1021/mp050043s.
14. Graham J.M. Homogenization of mammalian cultured cells. ScientificWorld Journal 2002, 2:1630-1633. 10.1100/tsw.2002.848.
15. Hildreth J., Sacks L., Hancock L.W. N-acetylneuraminic acid accumulation in a buoyant lysosomal fraction of cultured fibroblasts from patients with infantile generalized N-acetylneuraminic acid storage disease. Biochemical and Biophysical Research Communications 1986, 139(2):838-844.
16. Holtzman E. Lysosomes 1989, (New York).
17. Hornig-Do H.T., Gunther G., Bust M., Lehnartz P., Bosio A., Wiesner R.J. Isolation of functional pure mitochondria by superparamagnetic microbeads. Analytical Biochemistry 2009, 389(1):1-5. 10.1016/j.ab.2009.02.040.
18. Hua C.T., Hopwood J.J., Carlsson S.R., Harris R.J., Meikle P.J. Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clinical Chemistry 1998, 44(10):2094-2102.
19. Kirkbride K.C., Hong N.H., French C.L., Clark E.S., Jerome W.G., Weaver A.M. Regulation of late endosomal/lysosomal maturation and trafficking by cortactin affects golgi morphology. Cytoskeleton (Hoboken) 2012, 69(9):625-643. 10.1002/cm.21051.
20. +-ATPase of vacuoles of Saccharomyces carlsbergensis. FEBS Letters 1984, 174(2):233-237.
21. Lloyd-Evans E., Morgan A.J., He X., Smith D.A., Elliot-Smith E., Sillence D.J., et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nature Medicine 2008, 14(11):1247-1255. 10.1038/nm.1876.
22. Lloyd-Evans E., Platt F.M. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 2011, 50(2):200-205. 10.1016/j.ceca.2011.03.010.
23. Lloyd-Evans E., Waller-Evans H., Peterneva K., Platt F.M. Endolysosomal calcium regulation and disease. Biochemical Society Transactions 2010, 38(6):1458-1464. 10.1042/BST0381458.
24. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: fusion and function. Nature Reviews Molecular Cell Biology 2007, 8(8):622-632. 10.1038/nrm2217.
25. Manunta M., Izzo L., Duncan R., Jones A.T. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imaging. Journal of Drug Targeting 2007, 15(1):37-50. 10.1080/10611860601010330.
26. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nature Reviews Molecular Cell Biology 2007, 8(8):603-612. 10.1038/nrm2216.
27. Mayran N., Parton R.G., Gruenberg J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO Journal 2003, 22(13):3242-3253. 10.1093/emboj/cdg321.
28. Mendla K., Baumkotter J., Rosenau C., Ulrich-Bott B., Cantz M. Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease. Biochemical Journal 1988, 250(1):261-267.
29. Petri-Fink A., Chastellain M., Juillerat-Jeanneret L., Ferrari A., Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 2005, 26(15):2685-2694. 10.1016/j.biomaterials.2004.07.023.
30. Rodriguez-Paris J.M., Nolta K.V., Steck T.L. Characterization of lysosomes isolated from Dictyostelium discoideum by magnetic fractionation. The Journal of Biological Chemistry 1993, 268(12):9110-9116.
31. Ruas M., Rietdorf K., Arredouani A., Davis L.C., Lloyd-Evans E., Koegel H., et al. Purified TPC isoforms form NAADP receptors with distinct roles for Ca(2+) signaling and endolysosomal trafficking. Current Biology 2010, 20(8):703-709. 10.1016/j.cub.2010.02.049.
32. Santoyo Salazar Jaime, Perez Lucas, de Abril Oscar, Truong Phuoc Lai, Ihiawakrim Dris, Vazquez Manuel, et al. Magnetic iron oxide nanoparticles in 10-40nm range: composition in terms of magnetite/maghemite Ratio and effect on the magnetic properties. Chemistry of Materials 2011, 23(6):1379-1386. 10.1021/cm103188a.
33. Schneede A., Schmidt C.K., Holtta-Vuori M., Heeren J., Willenborg M., Blanz J., et al. Role for LAMP-2 in endosomal cholesterol transport. Journal of Cellular and Molecular Medicine 2011, 15(2):280-295. 10.1111/j.1582-4934.2009.00973.x.
34. Sillence D.J., Puri V., Marks D.L., Butters T.D., Dwek R.A., Pagano R.E., et al. Glucosylceramide modulates membrane traffic along the endocytic pathway. The Journal of Lipid Research 2002, 43(11):1837-1845.
35. Singh N., Jenkins G.J., Nelson B.C., Marquis B.J., Maffeis T.G., Brown A.P., et al. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012, 33(1):163-170. 10.1016/j.biomaterials.2011.09.087.
36. Tulp A., Verwoerd D., Pieters J. Application of an improved density gradient electrophoresis apparatus to the separation of proteins, cells and subcellular organelles. Electrophoresis 1993, 14(12):1295-1301.
37. Wahajuddin, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. International Journal of Nanomedicine 2012, 7:3445-3471. 10.2147/IJN.S30320.
38. Walker, M. W., Haslett, L. J., Williams, I. M., Waller-Evans, H., & Lloyd-Evans, E., Comparison of the effects of different superparamagnetic iron oxide nanoparticles on lysosomal and cellular toxicity, impact on utilisation for organelle purification and function. submitted.